VCEL Straddle Strategy
VCEL (Vericel Corporation), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; and Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns. Its preapproval stage product is NexoBrid, a registration-stage biological orphan product for eschar removal in adults with deep partial-thickness and/or full-thickness thermal burns. The company was formerly known as Aastrom Biosciences, Inc. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts.
VCEL (Vericel Corporation) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $1.68B, a trailing P/E of 77.69, a beta of 1.16 versus the broader market, a 52-week range of 28.95-45.97, average daily share volume of 654K, a public-listing history dating back to 1997, approximately 357 full-time employees. These structural characteristics shape how VCEL stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.16 places VCEL roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline. The trailing P/E of 77.69 is on the rich side, which tends to correlate with higher earnings-window IV expansion as the market debates whether forward growth supports the multiple.
What is a straddle on VCEL?
A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration.
Current VCEL snapshot
As of May 15, 2026, spot at $33.05, ATM IV 57.10%, IV rank 5.24%, expected move 16.37%. The straddle on VCEL below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this straddle structure on VCEL specifically: VCEL IV at 57.10% is on the cheap side of its 1-year range, which favors premium-buying structures like a VCEL straddle, with a market-implied 1-standard-deviation move of approximately 16.37% (roughly $5.41 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated VCEL expiries trade a higher absolute premium for lower per-day decay. Position sizing on VCEL should anchor to the underlying notional of $33.05 per share and to the trader's directional view on VCEL stock.
VCEL straddle setup
The VCEL straddle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With VCEL near $33.05, the first option leg uses a $33.05 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed VCEL chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 VCEL shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $33.05 | N/A |
| Buy 1 | Put | $33.05 | N/A |
VCEL straddle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit.
VCEL straddle payoff curve
Modeled P&L at expiration across a range of underlying prices for the straddle on VCEL. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use straddle on VCEL
Straddles on VCEL are pure-volatility plays that profit from large moves in either direction; traders typically buy VCEL straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
VCEL thesis for this straddle
The market-implied 1-standard-deviation range for VCEL extends from approximately $27.64 on the downside to $38.46 on the upside. A VCEL long straddle is a pure-volatility play: it profits when the underlying moves far enough from the strike in either direction to overcome the combined call plus put debit, regardless of direction. Current VCEL IV rank near 5.24% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on VCEL at 57.10%. As a Healthcare name, VCEL options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to VCEL-specific events.
VCEL straddle positions are structurally neutral / high-volatility (long premium); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. VCEL positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move VCEL alongside the broader basket even when VCEL-specific fundamentals are unchanged. Always rebuild the position from current VCEL chain quotes before placing a trade.
Frequently asked questions
- What is a straddle on VCEL?
- A straddle on VCEL is the straddle strategy applied to VCEL (stock). The strategy is structurally neutral / high-volatility (long premium): A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration. With VCEL stock trading near $33.05, the strikes shown on this page are snapped to the nearest listed VCEL chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are VCEL straddle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the VCEL straddle priced from the end-of-day chain at a 30-day expiry (ATM IV 57.10%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a VCEL straddle?
- The breakeven for the VCEL straddle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current VCEL market-implied 1-standard-deviation expected move is approximately 16.37%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a straddle on VCEL?
- Straddles on VCEL are pure-volatility plays that profit from large moves in either direction; traders typically buy VCEL straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
- How does current VCEL implied volatility affect this straddle?
- VCEL ATM IV is at 57.10% with IV rank near 5.24%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.